NCT02202746 · Interventional trial
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
Overall registry status Terminated
Phase 2
Conditions Breast Cancer, ER, Estrogen Receptor Positive, HER2, HER2 Positive, MBC, Metastatic Breast Cancer, Triple Negative
Delaware Valley sites
- Cooper University Hospital · Voorhees Township, NJ · Camden County
First posted
Registry updated
Added to the directory